ArticleFrontiers in immunology2026

Transitioning from efgartigimod to tacrolimus in chronic inflammatory demyelinating polyneuropathy: a prospective case series.

Yujia Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.